HeartSciences (HSCS) Stock: Buy, Sell, or Hold?
HSCS - HeartSciences Inc. Common Stock
$3.39
-0.12 (-3.42%)
▼
5d:
+0.89%
30d:
+69.5%
90d:
+80.32%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 10, 2026
0d
Get Alerted When HSCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HSCS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HSCS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: HSCS is currently trading at $3.39, which is considered extended relative to its 30-day fair value range of $2.09 to $3.38.
Technical Outlook: Technically, HSCS is in a uptrend. Immediate support is located at $2.90, while resistance sits at $4.35. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: HSCS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+184.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HSCS is in a uptrend. Immediate support is located at $2.90, while resistance sits at $4.35. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: HSCS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+184.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.09 -
$3.38
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 184.9% below Wall St target ($10.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.09 -
$3.38
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.90
Resistance Level
$4.35
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.24
Wall Street Target
$10.00
(+184.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 11, 2026 4:06 PM ET
Data refreshes hourly during market hours. Next update: 5:06 PM
Data refreshes hourly during market hours. Next update: 5:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 50 HOLD |
